Short-chain Fatty Acids In Control Of Body Weight And Insulin Sensitivity Pdf
- and pdf
- Monday, April 5, 2021 2:54:34 PM
- 1 comment
File Name: short-chain fatty acids in control of body weight and insulin sensitivity .zip
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI:
- Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
- Regulation of energy expenditure and substrate oxidation by short-chain fatty acids
- Short-chain fatty acids in control of body weight and insulin sensitivity
The connection between the gut microbiota and the aetiology of obesity and cardiometabolic disorders is increasingly being recognized by clinicians.
Many studies have identified that obesity is associated with a multitude of non-communicable diseases, such as cardiovascular disease, renal diseases, hypertension and type 2 diabetes Whitlock et al. Long-term body weight management could be improved by an increased intake of dietary fibre, as prospective cohort studies have shown that high-fibre diets are associated with lower weight gain Reynolds et al. In the United Kingdom, for instance, average daily fibre intake is
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI: Canfora and J. Jocken and E. Canfora , J. Jocken , E. The connection between the gut microbiota and the aetiology of obesity and cardiometabolic disorders is increasingly being recognized by clinicians.
Our gut microbiota might affect the cardiometabolic phenotype by fermenting indigestible dietary components and thereby producing short-chain fatty acids SCFA. View on Nature. Save to Library. Create Alert. Launch Research Feed.
Share This Paper. Background Citations. Methods Citations. Results Citations. Figures, Tables, and Topics from this paper. Figures and Tables. Paper Mentions. News Article. Medium US. Interventional Clinical Trial. Blog Post. PathVisio for full picture design! Citation Type. Has PDF. Publication Type. More Filters. Research Feed.
Short chain fatty acids in human gut and metabolic health. View 2 excerpts, cites background. Highly Influenced. View 5 excerpts, cites background. Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function.
Interplay between dietary fibers and gut microbiota for promoting metabolic health. Acetate: a diet-derived key metabolite in energy metabolism good or bad in context of obesity and glucose homeostasis? View 6 excerpts, cites background. View 1 excerpt, cites background.
Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 GPR Short chain fatty acids exchange across the gut and liver in humans measured at surgery.
The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
Regulation of energy expenditure and substrate oxidation by short-chain fatty acids
Hippocrate, Bruxelles, Belgium. Rizkalla, Florence Rossi, Francis R. Short-chain fructooligosaccharides FOS are prebiotics, which escape digestion in the small intestine and are fermented by the colonic microflora into short-chain fatty acids. Recently, we found that the daily consumption of 20 g FOS decreased basal hepatic glucose production in healthy subjects without any effect on insulin-stimulated glucose metabolism. In this study, we evaluated the effects of the chronic ingestion of FOS on plasma lipid and glucose concentrations, hepatic glucose production and insulin resistance in type 2 diabetics.
Short-chain fatty acids in control of body weight and insulin sensitivity
Medium chain triglycerides MCT have unique metabolic properties which may improve insulin sensitivity Si and beta cell function but data in humans are limited. We conducted a 6-week clinical trial of MCT oil supplementation. Dietary intake, PA data, body composition, and resting energy expenditure REE were obtained through dietary recall, international PA questionnaire, dual x-ray absorptiometry, and indirect calorimetry, respectively. Insulin-modified frequently sampled intravenous glucose tolerance tests were performed before and after MCT to measure changes in Si, acute insulin response AIR , disposition index DI , and glucose effectiveness Sg.